| Overexpression of the HMG‐CoA reductase gene leads to enhanced artemisinin biosynthesis in transgenic Artemisia annua plants S Aquil, AM Husaini, MZ Abdin, GM Rather Planta medica 75 (13), 1453-1458, 2009 | 141 | 2009 |
| Pharmacoinformatics approach for the identification of Polo-like kinase-1 inhibitors from natural sources as anti-cancer agents MF AlAjmi, MT Rehman, A Hussain, GM Rather International journal of biological macromolecules 116, 173-183, 2018 | 91 | 2018 |
| NAD- and NADPH-Contributing Enzymes as Therapeutic Targets in Cancer: An Overview AA Pramono, GM Rather, H Herman, K Lestari, JR Bertino Biomolecules 10, 358, 2020 | 71 | 2020 |
| High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1. Rehman MT, AlAjmi MF, Hussain A, Rather GM, Khan MA Int J Mol Sci 20 (4), E819, 2019 | 63 | 2019 |
| Toward point-of-care assessment of patient response: a portable tool for rapidly assessing cancer drug efficacy using multifrequency impedance cytometry and supervised machine … K Ahuja, GM Rather, Z Lin, J Sui, P Xie, T Le, JR Bertino, M Javanmard Microsystems & Nanoengineeringvolume 5 (34), 2019 | 58 | 2019 |
| In cancer, all roads lead to NADPH GM Rather, AA Pramono, Z Szekely, JR Bertino, PM Tedeschi Pharmacology & therapeutics 226, 107864, 2021 | 49 | 2021 |
| Rapid assessment of surface markers on cancer cells using immuno-magnetic separation and multi-frequency impedance cytometry for targeted therapy Z Lin, SY Lin, P Xie, CY Lin, GM Rather, JR Bertino, M Javanmard Scientific reports 10 (1), 3015, 2020 | 29 | 2020 |
| Non-chromatographic strategies for protein refolding S Gautam, P Dubey, G Mohmad Rather, M N Gupta Recent Patents on Biotechnology 6 (1), 57-68, 2012 | 28 | 2012 |
| Activation of alpha chymotrypsin by three phase partitioning is accompanied by aggregation GM Rather, J Mukherjee, PJ Halling, MN Gupta PLoS One 7 (12), e49241, 2012 | 24 | 2012 |
| Three phase partitioning leads to subtle structural changes in proteins GM Rather, MN Gupta International journal of biological macromolecules 60, 134-140, 2013 | 21 | 2013 |
| Glucoamylase from a newly isolated Aspergillus niger FME: Detergent-Mediated production, purification, and characterization SK Gudi, C Gurramkonda, G Rather, MGS Chandra, UK Mangamuri, ... Journal of the Korean Society for Applied Biological Chemistry 56, 427-433, 2013 | 18 | 2013 |
| 2D magnetic sensor array for real-time cell tracking and multi-site detection with increased robustness and flow-rate H Tang, S Venkatesh, Z Lin, X Lu, H Saeidi, GM Rather, JR Bertino, ... 2019 IEEE Custom Integrated Circuits Conference (CICC), 1-4, 2019 | 14 | 2019 |
| pH-dependent urea-induced unfolding of stem bromelain: unusual stability against urea at neutral pH B Ahmad, GM Rathar, A Varshney, RH Khan Biochemistry (Moscow) 74, 1337-1343, 2009 | 13 | 2009 |
| Thermostable α‐amylase immobilization: Enhanced stability and performance for starch biocatalysis GS Kumar, GM Rather, C Gurramkonda, BR Reddy Biotechnology and Applied Biochemistry 63 (1), 57-66, 2016 | 12 | 2016 |
| Activated matriptase as a target to treat breast cancer with a drug conjugate GM Rather, SY Lin, H Lin, W Banach-Petrosky, KM Hirshfield, CY Lin, ... Oncotarget 9 (40), 25983, 2018 | 11 | 2018 |
| Refolding of urea denatured ovalbumin with three phase partitioning generates many conformational variants GM Rather, MN Gupta International journal of biological macromolecules 60, 301-308, 2013 | 11 | 2013 |
| Modeling and antitumor studies of a modified L–penetratin peptide targeting E2F in lung cancer and prostate cancer T Shaik, GM Rather, N Bansal, T Minko, O Garbuzenko, Z Szekely, ... Oncotarget 9 (70), 33249, 2018 | 9 | 2018 |
| Translational research of PT-112, a clinical agent in advanced phase i development: Evident bone tropism, synergy in vitro with bortezomib and lenalidomide, and potent efficacy … TD Ames, ME Sharik, GM Rather, G Hochart, D Bonnel, S Linehan, ... Blood 130, 1797, 2017 | 7 | 2017 |
| Anti-Tumor Effects of a Penetratin Peptide Targeting Transcription of E2F-1, 2 and 3a Is Enhanced When Used in Combination with Pemetrexed or Cisplatin GM Rather, M Anyanwu, T Minko, O Garbuzenko, Z Szekely, JR Bertino Cancers 13 (5), 972, 2021 | 3 | 2021 |
| A novel antibody-toxin conjugate to treat mantle cell lymphoma GM Rather, SY Lin, H Lin, Z Szekely, JR Bertino Frontiers in oncology 9, 258, 2019 | 3 | 2019 |
